Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-76
Closed -$7K 1169
2025
Q2
$7K Buy
76
+53
+230% +$5.01K ﹤0.01% 539
2025
Q1
$2K Hold
23
﹤0.01% 688
2024
Q4
$2K Buy
23
+18
+360% +$1.65K ﹤0.01% 685
2024
Q3
$0 Hold
5
﹤0.01% 972
2024
Q2
$0 Buy
+5
New +$464 ﹤0.01% 884
2022
Q3
Sell
-1
Closed 510
2022
Q2
$0 Buy
+1
New +$128 ﹤0.01% 513
2022
Q1
Sell
-51
Closed -$8K 398
2021
Q4
$8K Buy
+51
New +$8.2K ﹤0.01% 251

Other funds holding AMED

Avion Wealth's AMED Position: Q3 2025 in Review

Avion Wealth sold out of Amedisys (AMED) in Q3 2025, closing a stake of 76 shares — an estimated $7K sold.

Avion Wealth first reported a position in AMED in Q4 2021 and held it in 7 quarters. The position peaked at $8K in Q4 2021. 4 funds tracked by Wall St. Rank hold AMED as of Q3 2025.

  • Avion Wealth reported no remaining Amedisys position as of Q3 2025 after selling out during the quarter.
  • Avion Wealth sold 76 Amedisys shares in Q3 2025, an estimated $7K.
  • Avion Wealth first reported a position in Amedisys in Q4 2021 and held it in 7 quarters.
  • Avion Wealth's Amedisys position peaked at $8K in Q4 2021.
  • 4 funds tracked by Wall St. Rank held Amedisys as of Q3 2025.

Based on Avion Wealth's 13F filing for Q3 2025, filed 24 Oct 2025.